FDA Calendar
Upcoming clinical readouts, trial starts, and trial-progress milestones for U.S.-listed biotech, with official source links.
FREE BETA · Guests can view 30 days, including today (through Nov 10, 2026, ET). Sign in for the full calendar.
1 of 1,611 scheduled catalysts · 1 of 429 companies with matching events
Evidence: A regulator/SEC/trial registry · B official company source · Market data is separate context.
Scheduled catalysts
Scroll the table horizontally to view all columns →
Next CatalystCompanyDrugPrice · 30DCurrent stage
Shattuck Labs, Inc.STTK
DrugSL-846bispecific antibody
IndicationNon-human primates (IND-enabling GLP toxicology)SL-846 IND-enabling GLP toxicology study · non-human primates
TargetDR3 / IL-23R
Clinical dataPreclinical dataOct 17-20, 2026UEG WeekAOfficial source
Study details
SL-846 IND-enabling GLP toxicology study · Preclinical data for SL-846, including safety, pharmacokinetics, and receptor occupancy from the ongoing GLP toxicology study
Current stage
PreINDP1P2P3FilingApproved
Price · 30D
$5.66-8.0%
30D · 10/09